Vimarsana
Biggest News Aggregation in the World

Roberto Solari News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roberto Solari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roberto Solari Today - Breaking & Trending Today

Enhanced Potential of Myricx's NMT Inhibitor Payloads with Dual Senolytic and Cytotoxic Modes of Action as ADC Cancer Therapies - Vimarsana News

Enhanced Potential of Myricx's NMT Inhibitor Payloads with Dual Senolytic and Cytotoxic Modes of Action as ADC Cancer Therapies

Enhanced Potential of Myricx’s NMT Inhibitor Payloads with Dual Senolytic and Cytotoxic Modes of Action as ADC Cancer Therapies

Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics - Vimarsana News

Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics

LONDON and SHANGHAI, China, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announce that they have entered into a license agreement under which Myricx will have exclusive

Source: yahoo.com
Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur - Vimarsana News

Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur

LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel...

Myricx Enters into Antibody License Agreement with - Vimarsana News

Myricx Enters into Antibody License Agreement with

LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel...

Brandon Capital co-Leads USD68M Series A Financing of London-Based ADC Company Pheon Therapeutics - Vimarsana News

Brandon Capital co-Leads USD68M Series A Financing of London-Based ADC Company Pheon Therapeutics

Financing led by Brandon Capital from its newly established UK operation; Forbion and Atlas Venture co-led the round USD68M series A will enable London-based...